MENU

These 3 small cap ASX shares are pushing higher on Friday

The market may be pushing notably higher today, but its gain pales in comparison to some being made at the small end of the market.

Three small cap shares that have caught the eye today are listed below. Here’s why they are on the up:

The Avita Medical Ltd (ASX: AVH) share price has risen 10% to 9.9 cents after the regenerative medicine company announced that the U.S. Food and Drug Administration (FDA) approved its Premarket Approval application to market the RECELL Autologous Cell Harvesting Device to treat severe thermal burns in patients 18 years and older. The company expects to launch the RECELL System in the U.S. in the fourth quarter of 2018. Management estimates that the product has an addressable market worth approximately US$200 million.

The Imugene Limited (ASX: IMU) share price has risen 4.5% to 2.3 cents after the clinical stage immuno-oncology company announced that it has formally commenced cGMP manufacture of the clinical batch of cancer vaccine KEY-Vaxx for its proposed Phase 1 PD-1 clinical trial to be conducted in 2019. AmbioPharm Inc, a US-based full-service peptide manufacturing company, has been appointed by the company.

The King River Copper Ltd (ASX: KRC) share price has surged 18% to 5.9 cents after the mineral exploration company was the subject of a now deleted article on the AFR website. That article was titled “Vanadium discoveries a battery game changer” and appears to have got investors excited. King River Copper management quickly put its shares in a trading halt and have clarified details of the article. It stated that “the outcomes of current Scoping Studies are still to be completed and investors should await the release of this information. Scoping on the Vanadium, Titanium, Iron and the Fluorspar projects is expected in the coming weeks.” I would suggest investors follow management’s advice and wait patiently for further details.

Motley Fool Australia Issues Rare "Double Down" Buy Alert

Scott Phillips has stumbled upon a little-owned stock he believes could be one of the greatest discoveries of his 25 years as a professional investor.

 

This is your chance to get in early on of what could prove to be a very special investment recommendation. Think about how many investing trends you've missed out on, even though you knew they were going to be big. Don't let that happen again. This is your chance to get in early.

Simply click here to get started and access our secure sign-up page.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…

Including:

The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!